Meeder Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3
Closed -$1K 2579
2021
Q3
$1K Sell
3
-6,396
-100% -$1.18M ﹤0.01% 2423
2021
Q2
$1.18M Sell
6,399
-2,699
-30% -$463K 0.05% 246
2021
Q1
$1.39M Buy
9,098
+8,031
+753% +$1.24M 0.07% 216
2020
Q4
$167K Sell
1,067
-19,734
-95% -$2.54M 0.04% 333
2020
Q3
$2.38M Sell
20,801
-135
-0.6% -$14.6K 0.15% 120
2020
Q2
$2.35M Sell
20,936
-6,000
-22% -$637K 0.15% 120
2020
Q1
$2.42M Sell
26,936
-1,283
-5% -$126K 0.19% 109
2019
Q4
$3.05M Buy
28,219
+5,708
+25% +$611K 0.19% 116
2019
Q3
$2.2M Sell
22,511
-16,406
-42% -$1.85M 0.15% 130
2019
Q2
$5.1M Buy
38,917
+1,174
+3% +$151K 0.36% 80
2019
Q1
$5.1M Buy
37,743
+17,771
+89% +$2.21M 0.4% 73
2018
Q4
$1.95M Buy
19,972
+3,340
+20% +$395K 0.17% 114
2018
Q3
$2.31M Buy
16,632
+748
+5% +$93.8K 0.17% 128
2018
Q2
$1.97M Buy
15,884
+8,216
+107% +$960K 0.17% 130
2018
Q1
$855K Buy
7,668
+3,072
+67% +$367K 0.08% 245
2017
Q4
$549K Buy
4,596
+1,193
+35% +$145K 0.05% 335
2017
Q3
$478K Buy
3,403
+2,919
+603% +$397K 0.05% 367
2017
Q2
$59K Sell
484
-431
-47% -$50.2K 0.01% 651
2017
Q1
$111K Buy
+915
New +$118K 0.01% 548
2016
Q4
Sell
-1,116
Closed -$137K 1092
2016
Q3
$137K Sell
1,116
-5,005
-82% -$644K 0.01% 576
2016
Q2
$715K Buy
6,121
+5,306
+651% +$753K 0.07% 300
2016
Q1
$114K Buy
+815
New +$120K 0.01% 678
2015
Q2
Sell
-7,335
Closed -$1.27M 541
2015
Q1
$1.27M Hold
7,335
0.14% 203
2014
Q4
$1.36M Buy
+7,335
New +$1.36M 0.17% 157

Other funds holding ALXN